title: Prognostic significance of cyclin expression in human osteosarcoma.
abstract: To evaluate the distribution of cyclin protein expression, in relation to cell proliferation rate and clinical behavior, an immunohistochemical study was performed on 92 tumor samples of patients with high grade osteosarcoma (OS). A large cyclin A- and cyclin E-positive fraction was found respectively in 59% and 47% of the osteosarcomas, while immunostaining for cyclin D1 was weak or absent in most tumor samples. A positive, statistically significant correlation was found between A and E cyclins and Ki67 expression (p<0.001). Disease-free survival (DFS) analysis included 69 of the 92 patients. A significantly higher probability of metastasis was seen in patients lacking cyclin D1 compared to those in which cyclin D1 was positive (p<0.01). Conversely, patients with >40% of cyclin A-positive cells relapsed more frequently than those with <40% of cyclin A-positive cells (p<0.05). The multivariate analysis demonstrated that cyclin A had a lower predective risk in terms of disease-free survival as opposed to the loss of cyclin D1 that is considered a powerful prognostic factor.
authors.affiliation: Laboratory of Oncologic Research, Rizzoli Orthopaedic Institute, Bologna, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Molendini
authors.forename: M S
authors.initials: MS
authors.lastname: Benassi
authors.forename: G
authors.initials: G
authors.lastname: Magagnoli
authors.forename: M
authors.initials: M
authors.lastname: Merli
authors.forename: M R
authors.initials: MR
authors.lastname: Sollazzo
authors.forename: P
authors.initials: P
authors.lastname: Ragazzini
authors.forename: G
authors.initials: G
authors.lastname: Gamberi
authors.forename: C
authors.initials: C
authors.lastname: Ferrari
authors.forename: A
authors.initials: A
authors.lastname: Balladelli
authors.forename: P
authors.initials: P
authors.lastname: Bacchini
authors.forename: P
authors.initials: P
authors.lastname: Picci
mesh_terms: D001706:Biopsy; D001859:Bone Neoplasms / Q000401:mortality / Q000473:pathology*; D019925:Cyclin A / Q000032:analysis* / Q000096:biosynthesis; D019927:Cyclin E / Q000032:analysis* / Q000096:biosynthesis; D018572:Disease-Free Survival; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis; D015999:Multivariate Analysis; D009362:Neoplasm Metastasis; D012516:Osteosarcoma / Q000401:mortality / Q000473:pathology*; D011336:Probability; D011379:Prognosis; D012008:Recurrence; D012044:Regression Analysis; D015996:Survival Rate
chemical_list: D019925:Cyclin A; D019927:Cyclin E; D019394:Ki-67 Antigen